317 results
Page 15 of 16
8-K
EX-99.1
0m1mk2 urcio
25 Jan 06
Alnylam Announces Allowance of Additional U.S. Patent Broadly Covering RNAi Therapeutics
12:00am
424B5
cs23z5m82qwr2f4pm
24 Jan 06
Prospectus supplement for primary offering
12:00am
8-K
EX-99.1
bdfibzb
9 Nov 05
Results of Operations and Financial Condition
12:00am
8-K
EX-10.1
s37fgqk5zx vrele3
12 Oct 05
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.3
bibi9y5v etfi
12 Sep 05
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
p6x3ur a3
12 Sep 05
Entry into a Material Definitive Agreement
12:00am
8-K
EX-99.1
pv99 aap7m
3 Aug 05
Results of Operations and Financial Condition
12:00am
10-K
5873gl58m4xps
30 Mar 05
Annual report
12:00am
8-K
EX-99.1
6x5mjb5c8
15 Feb 05
Results of Operations and Financial Condition
12:00am
8-K
EX-99.1
pno1qsjbx0f
10 Nov 04
Alnylam Pharmaceuticals Reports Third Quarter 2004 Financial Results
12:00am
10-Q
qyssfm7rh476w01k50
12 Aug 04
Quarterly report
12:00am
10-Q
EX-10.1
5qn40rday9fzd9
12 Aug 04
Quarterly report
12:00am
8-K
EX-99.1
6d8jogwf4scf2j0vstkk
4 Aug 04
Alnylam Pharmaceuticals Reports Second Quarter 2004 Financial Results
12:00am
8-K
EX-99.1
i4xt7pzo
2 Jul 04
Merck and Alnylam Establish New Strategic Alliance to Co-Develop and Co-Commercialize RNAi Therapeutics for Ocular Diseases
12:00am
424B4
td1psovxlkxmbf4t
28 May 04
Prospectus supplement with pricing info
12:00am